EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C

Hojatollah Jaldi iD, Tshilidzi van der Lecq iD

Journal of the Colleges of Medicine of South Africa · 26.05.2026 · 4 (1)

DOI: 10.4102/jcmsa.v4i1.362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Colleges of Medicine of South Africa, online erschienen am 26.05.2026. Verfasst von Hojatollah Jaldi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Ophthalmology, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Ahmed Glaucoma Valve (AGV) is a commonly used glaucoma drainage device (GDD) in the surgical management of glaucoma patients. Adjunctive mitomycin C (MMC) has demonstrated clear benefits in improving the surgical outcomes of trabeculectomy surgery. The effectiveness of MMC in improving the surgical outcomes of GDDs remains uncertain. This study seeks to compare the surgical outcomes of AGV implantation with and without the use of intraoperative MMC in an African cohort.

Methods

This retrospective case series analysed 98 eyes in 95 patients who underwent AGV implantation from 01 January 2016 to 31 December 2021 at two units located in Cape Town, South Africa. The postoperative data collected included intraocular pressure (IOP), medication use, and complications.

Results

The eyes were categorised into the MMC use (n = 46) or non-MMC use (n = 52) group. In most eyes within the MMC use group (78.3%, n = 36), a concentration of 0.2 mg/mL was used. The mean preoperative IOP in the MMC group and the non-MMC group was 38 and 33, respectively (p = 0.12). At 1 year, the mean IOP in the MMC use group (n = 31) was 18 mmHg and 16 mmHg in the non-MMC group (n = 36) (p = 0.84). The frequency of complications and the hypertensive phase were comparable in the two groups.

Conclusion

This study found no difference between the two groups in terms of IOP control, postoperative medication use, and complications. This may be attributed to the low concentration of MMC used in our cohort. Contribution: This study provides insights into the role of MMC use in AGV implantation.

Schlagwörter

Stichwörter der Autor:innen

AfricanAhmed Glaucoma ValveMitomycin Cglaucomaglaucoma drainage devicesintraocular pressurepostoperative outcomessurgical outcomes

Autor:innen und Institutionen

  • Division of Ophthalmology, Department of Surgery, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Hojatollah Jaldi, Tshilidzi van der Lecq

Zitieren

APA

Jaldi, H., & van der Lecq, T. (2026). Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C. Journal of the Colleges of Medicine of South Africa, 4(1). https://doi.org/10.4102/jcmsa.v4i1.362

Vancouver

Jaldi H, van der Lecq T. Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C. Journal of the Colleges of Medicine of South Africa. 2026;4(1). doi:10.4102/jcmsa.v4i1.362

BibTeX
@article{Jaldi2026,
  author = {Jaldi, Hojatollah and van der Lecq, Tshilidzi},
  title = {Surgical outcomes of Ahmed Glaucoma Valve Implantation surgery: With mitomycin C and without mitomycin C},
  journal = {Journal of the Colleges of Medicine of South Africa},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.4102/jcmsa.v4i1.362}
}
Kostenlos starten →